These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26598688)
1. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. Rossi M; Ruiz de Azua I; Barella LF; Sakamoto W; Zhu L; Cui Y; Lu H; Rebholz H; Matschinsky FM; Doliba NM; Butcher AJ; Tobin AB; Wess J Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6818-24. PubMed ID: 26598688 [TBL] [Abstract][Full Text] [Related]
2. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Ruiz de Azua I; Scarselli M; Rosemond E; Gautam D; Jou W; Gavrilova O; Ebert PJ; Levitt P; Wess J Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7999-8004. PubMed ID: 20385802 [TBL] [Abstract][Full Text] [Related]
4. Beneficial metabolic effects caused by persistent activation of beta-cell M3 muscarinic acetylcholine receptors in transgenic mice. Gautam D; Ruiz de Azua I; Li JH; Guettier JM; Heard T; Cui Y; Lu H; Jou W; Gavrilova O; Zawalich WS; Wess J Endocrinology; 2010 Nov; 151(11):5185-94. PubMed ID: 20843999 [TBL] [Abstract][Full Text] [Related]
5. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells. Nakajima K; Jain S; Ruiz de Azua I; McMillin SM; Rossi M; Wess J Mol Endocrinol; 2013 Aug; 27(8):1208-16. PubMed ID: 23820900 [TBL] [Abstract][Full Text] [Related]
6. Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo. Ruiz de Azua I; Nakajima K; Rossi M; Cui Y; Jou W; Gavrilova O; Wess J FASEB J; 2012 Oct; 26(10):4275-86. PubMed ID: 22730439 [TBL] [Abstract][Full Text] [Related]
7. Regulator of G-protein signaling Gβ5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion. Wang Q; Pronin AN; Levay K; Almaca J; Fornoni A; Caicedo A; Slepak VZ FASEB J; 2017 Nov; 31(11):4734-4744. PubMed ID: 28687610 [TBL] [Abstract][Full Text] [Related]
8. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications. Ruiz de Azua I; Gautam D; Guettier JM; Wess J Trends Endocrinol Metab; 2011 Feb; 22(2):74-80. PubMed ID: 21106385 [TBL] [Abstract][Full Text] [Related]
9. Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets. Hauge-Evans AC; Reers C; Kerby A; Franklin Z; Amisten S; King AJ; Hassan Z; Vilches-Flores A; Tippu Z; Persaud SJ; Jones PM Diabetes Obes Metab; 2014 Oct; 16(10):947-56. PubMed ID: 24720683 [TBL] [Abstract][Full Text] [Related]
10. Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1. Becker A; Götz C; Montenarh M; Philipp SE Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884938 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2. Torrecilla I; Spragg EJ; Poulin B; McWilliams PJ; Mistry SC; Blaukat A; Tobin AB J Cell Biol; 2007 Apr; 177(1):127-37. PubMed ID: 17403928 [TBL] [Abstract][Full Text] [Related]
12. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Gautam D; Han SJ; Hamdan FF; Jeon J; Li B; Li JH; Cui Y; Mears D; Lu H; Deng C; Heard T; Wess J Cell Metab; 2006 Jun; 3(6):449-61. PubMed ID: 16753580 [TBL] [Abstract][Full Text] [Related]
13. M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Kong KC; Butcher AJ; McWilliams P; Jones D; Wess J; Hamdan FF; Werry T; Rosethorne EM; Charlton SJ; Munson SE; Cragg HA; Smart AD; Tobin AB Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21181-6. PubMed ID: 21078968 [TBL] [Abstract][Full Text] [Related]
14. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor. Weston-Green K; Huang XF; Deng C CNS Drugs; 2013 Dec; 27(12):1069-80. PubMed ID: 24114586 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor. Doliba NM; Liu Q; Li C; Chen P; Liu C; Naji A; Matschinsky FM Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723 [TBL] [Abstract][Full Text] [Related]
16. The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islets. Meng R; Götz C; Montenarh M Biochem Biophys Res Commun; 2010 Oct; 401(2):203-6. PubMed ID: 20849816 [TBL] [Abstract][Full Text] [Related]
17. Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147. Rosemond E; Rossi M; McMillin SM; Scarselli M; Donaldson JG; Wess J Mol Pharmacol; 2011 Feb; 79(2):251-61. PubMed ID: 21056967 [TBL] [Abstract][Full Text] [Related]
18. CK2 activity is crucial for proper glucagon expression. Ampofo E; Pack M; Wrublewsky S; Boewe AS; Spigelman AF; Koch H; MacDonald PE; Laschke MW; Montenarh M; Götz C Diabetologia; 2024 Jul; 67(7):1368-1385. PubMed ID: 38503901 [TBL] [Abstract][Full Text] [Related]
19. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. Scarselli M; Li B; Kim SK; Wess J J Biol Chem; 2007 Mar; 282(10):7385-96. PubMed ID: 17213190 [TBL] [Abstract][Full Text] [Related]
20. Protein Kinase CK2 Controls Ca Scheuer R; Philipp SE; Becker A; Nalbach L; Ampofo E; Montenarh M; Götz C Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]